Monday, February 08, 2010 | Register | Login |   Search      
 

Cyanta Analytical Laboratories
Cyanta provides comprehensive analytical services to support pharmaceutical, biotech and medical device companies. We specialize in providing cGMP studies to support our clients regulatory filings.
Our services include:

Analytical Method Development Services
Cyanta provides early phase development and investigative methods for material characterization and identification.
 
Method Validation and Stability Services
Cyanta provides both long and short-term stability storage and analytical services including validation of stability indicating assays.
 
Preformulation Support Services
Our team is experienced in the design and execution of preformulation studies for pharmaceutical development
 
Extractables and Leachables
Cyanta provides a variety of services to investigate the interaction between your drug product and medical device. These include compositional analysis, degradation testing, polymers and material analysis and stability evaluations.
 
Inhalation Development Services
Cyanta provides a full complement of analytical support for all inhalation and nasal spray dosage forms
 
Product and Material Characterization
From impurity identification to primary reference standards, our synthetic, organic, and analytical chemists can assist with routine or challenging characterization projects.
 
Biopharmaceutical Testing
Our experience in large molecule characterization and conjugate synthesis gives us the tools to be successful in delivering optimal product stability and bioactivity for our clients’ large molecule projects.
 
Quality Control & Release Testing
Cyanta offers QC testing for Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, excipients and finished products.
 
Consulting & Litigation Support
Cyanta specializes in providing legal support to investigate impurities and patent infringement with your pharmaceutical product.
 

 
Press Releases

November 11, 2008

 
Azopharma Unveils New UK Laboratory and EU plans
 
HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the European market with the addition of new laboratory facilities and office space located in Welwyn Garden City, UK. The new facility will provide analytical, QP release testing, preformulation and formulation development services to the European market.
 
Mr. Phil Meeks, CEO of Azopharma Product Development Group says, “This is a very exciting time for Azopharma with our first venture outside the USA. Our vision for the new laboratory is to provide key product development services to our many clients in Europe. We see this facility as the first step in bringing our complete service offerings to the region.”
Read More

 

Trade Shows

AAPS Annual Meeting, Los Angeles, CA
November 2009





Copyright ©2007 Cyanta Analytical Laboratories   Terms Of Use   Privacy Statement   Site Map